Type 2 Diabetes and Prediabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals diagnosed with type 2 diabetes or prediabetes 2. Individuals who are currently receiving either pharmacotherapy, exercise therapy, or dietary therapy for the above condition 3. Male or female individuals aged 20 years or older and under 90 years
Exclusion criteria
Exclusion criteria: 1. Individuals diagnosed with type 1 diabetes 2. Individuals for whom participation in the study is considered difficult due to dementia, psychiatric disorders, or similar conditions 3. Individuals deemed inappropriate for participation by the attending physician or principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The time course of blood glucose levels will be continuously measured every 15 minutes using FreeStyle Libre before the intervention period, immediately after the start of the intervention, and just before the end of the intervention. Blood glucose fluctuations will be evaluated based on the area under the concentration-time curve (AUC) and the maximum blood concentration (Cmax); however, the calculation methods for these evaluation metrics themselves will also be a subject of investigation in this study. | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA1c and fructosamine will be measured before, during, and after the intervention. | — |
Countries
Japan
Contacts
National Center of Neurology and Psychiatry Department of Information Medicine, National Institute of Neuroscience